14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.91 $2.61 Friday, 3rd May 2024 CHRS stock ended at $2.27. This is 4.61% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 6.02% from a day low at $2.19 to a day high of $2.32.
90 days $1.91 $2.87
52 weeks $1.44 $8.22

Historical Coherus BioSciences prices

Date Open High Low Close Volume
May 05, 2023 $7.38 $7.60 $7.27 $7.38 574 735
May 04, 2023 $7.26 $7.67 $7.07 $7.32 551 444
May 03, 2023 $7.28 $7.48 $7.11 $7.30 749 366
May 02, 2023 $7.62 $7.68 $7.13 $7.17 1 004 803
May 01, 2023 $7.49 $8.00 $7.39 $7.67 1 006 475
Apr 28, 2023 $7.20 $7.37 $7.09 $7.23 497 846
Apr 27, 2023 $7.55 $7.63 $7.21 $7.24 572 505
Apr 26, 2023 $7.80 $7.90 $7.46 $7.51 902 004
Apr 25, 2023 $8.01 $8.13 $7.71 $7.78 528 598
Apr 24, 2023 $8.31 $8.33 $7.99 $8.06 402 757
Apr 21, 2023 $7.99 $8.31 $7.95 $8.30 622 433
Apr 20, 2023 $8.05 $8.24 $7.87 $7.97 626 196
Apr 19, 2023 $8.06 $8.34 $8.02 $8.15 551 761
Apr 18, 2023 $8.29 $8.29 $7.78 $8.17 778 319
Apr 17, 2023 $8.00 $8.65 $7.95 $8.23 1 327 681
Apr 14, 2023 $8.36 $8.36 $7.72 $7.88 699 553
Apr 13, 2023 $7.81 $8.14 $7.67 $8.13 811 292
Apr 12, 2023 $8.00 $8.00 $7.69 $7.70 843 301
Apr 11, 2023 $7.84 $7.97 $7.58 $7.80 561 637
Apr 10, 2023 $7.67 $7.94 $7.63 $7.84 1 658 081
Apr 06, 2023 $7.65 $7.74 $7.58 $7.66 724 039
Apr 05, 2023 $7.43 $7.82 $7.38 $7.68 758 571
Apr 04, 2023 $7.50 $7.62 $7.26 $7.45 1 419 949
Apr 03, 2023 $6.81 $7.51 $6.53 $7.48 1 072 185
Mar 31, 2023 $6.51 $6.86 $6.51 $6.84 1 095 669
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT